Literature DB >> 22697056

Translational neuroprotection research in glaucoma: a review of definitions and principles.

Robert J Casson1, Glyn Chidlow, Andreas Ebneter, John P M Wood, Jonathan Crowston, Ivan Goldberg.   

Abstract

The maintenance of vision, through prevention and attenuation of neuronal injury in glaucoma, forms the basis of current clinical practice. Currently, the reduction of intraocular pressure is the only proven method to achieve these goals. Although this strategy enjoys considerable success, some patients progress to blindness; hence, additional management options are highly desirable. Several terms describing treatment modalities of neuronal diseases with potential applicability to glaucoma are used in the literature, including neuroprotection, neurorecovery, neurorescue and neuroregeneration. These phenomena have not been defined within a coherent framework. Here, we suggest a set of definitions, postulates and principles to form a foundation for the successful translation of novel glaucoma therapies from the laboratory to the clinic.
© 2011 The Authors. Clinical and Experimental Ophthalmology © 2011 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22697056     DOI: 10.1111/j.1442-9071.2011.02563.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  18 in total

1.  Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.

Authors:  Arzu Toruk Aksar; Nursen Yuksel; Mustafa Gok; Mustafa Cekmen; Yusuf Caglar
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.

Authors:  Thomas V Johnson; Nicholas W DeKorver; Victoria A Levasseur; Andrew Osborne; Alessia Tassoni; Barbara Lorber; Janosch P Heller; Rafael Villasmil; Natalie D Bull; Keith R Martin; Stanislav I Tomarev
Journal:  Brain       Date:  2013-10-30       Impact factor: 13.501

3.  Neuroprotective effects of bikaverin on H2O2-induced oxidative stress mediated neuronal damage in SH-SY5Y cell line.

Authors:  D Nirmaladevi; M Venkataramana; S Chandranayaka; A Ramesha; N M Jameel; C Srinivas
Journal:  Cell Mol Neurobiol       Date:  2014-05-22       Impact factor: 5.046

Review 4.  Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.

Authors:  Kimberly A Fernandes; Jeffrey M Harder; Pete A Williams; Rebecca L Rausch; Amy E Kiernan; K Saidas Nair; Michael G Anderson; Simon W M John; Gareth R Howell; Richard T Libby
Journal:  Exp Eye Res       Date:  2015-06-24       Impact factor: 3.467

5.  Differential up-regulation of Vesl-1/Homer 1 protein isoforms associated with decline in visual performance in a preclinical glaucoma model.

Authors:  Simon Kaja; Yuliya Naumchuk; Stephanie L Grillo; Priscilla K Borden; Peter Koulen
Journal:  Vision Res       Date:  2013-11-09       Impact factor: 1.886

6.  Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork.

Authors:  Jintao Cheng; Jiamei Liang; Jinze Qi
Journal:  Exp Ther Med       Date:  2017-06-02       Impact factor: 2.447

Review 7.  Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage ("Neuroprotection").

Authors:  Heinz Wiendl; Christian Elger; Hans Förstl; Hans-Peter Hartung; Wolfgang Oertel; Heinz Reichmann; Stefan Schwab
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

8.  The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study.

Authors:  Miriam Kolko; Anna Horwitz; John Thygesen; Jørgen Jeppesen; Christian Torp-Pedersen
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

9.  Heat shock response and homeostatic plasticity.

Authors:  Shanker Karunanithi; Ian R Brown
Journal:  Front Cell Neurosci       Date:  2015-03-12       Impact factor: 5.505

Review 10.  Neuropharmacological effects of Nigella sativa.

Authors:  Farimah Beheshti; Majid Khazaei; Mahmoud Hosseini
Journal:  Avicenna J Phytomed       Date:  2016 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.